Table 1.
Phosphoprotein screening results from AGASACA and TC tumor samples
| RTK | Primary AGASACA n (%) | Metastatic AGASACA n (%) | Thyroid carcinoma n (%) |
|---|---|---|---|
| EGFR |
16 (67) |
7 (64) |
14 (100)* |
| Dtk/TYRO3 |
21 (87) |
3 (27) |
8 (53) |
| Insulin-R |
12 (50) |
1 (9) |
6 (40) |
| ROR-1 |
22 (92) |
11 (100) |
15 (100) |
| ROR-2 |
15 (62) |
- |
- |
| Ret |
13 (54) |
1 (9) |
3 (20) |
| Tie-1 |
5 (21) |
11 (100) |
15 (100) |
| Tie-2 |
6 (25) |
1 (9) |
6 (40) |
| Ron |
13 (54) |
1 (9) |
5 (30) |
| FGFR3 | 9 (38) | 1 (9) | - |